These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 9058668

  • 1. Antinuclear antibody positivity in pediatric patients with autoimmune thyroid disease.
    Inamo Y, Harada K.
    J Rheumatol; 1997 Mar; 24(3):576-8. PubMed ID: 9058668
    [Abstract] [Full Text] [Related]

  • 2. Association of circulating antibodies against double-stranded and single-stranded DNA with thyroid autoantibodies in Graves' disease and Hashimoto's thyroiditis patients.
    Pedro AB, Romaldini JH, Americo C, Takei K.
    Exp Clin Endocrinol Diabetes; 2006 Jan; 114(1):35-8. PubMed ID: 16450315
    [Abstract] [Full Text] [Related]

  • 3. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
    Zwirska-Korczala K, Berdowska A, Jochem J, Sitkiewicz A, Birkner E, Polaniak R, Jedrzejowska-Szypułka H, Korzonek-Szlacheta I.
    J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
    [Abstract] [Full Text] [Related]

  • 4. Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy.
    Antonelli A, Rotondi M, Fallahi P, Romagnani P, Ferrari SM, Barani L, Ferrannini E, Serio M.
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):189-95. PubMed ID: 16430719
    [Abstract] [Full Text] [Related]

  • 5. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
    Harper L, Chin L, Daykin J, Allahabadia A, Heward J, Gough SC, Savage CO, Franklyn JA.
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):671-5. PubMed ID: 15163328
    [Abstract] [Full Text] [Related]

  • 6. Treatment outcome of Graves' disease in Thai children.
    Somnuke PH, Pusuwan P, Likitmaskul S, Santiprabhob J, Sawathiparnich P.
    J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
    [Abstract] [Full Text] [Related]

  • 7. The presence of the antigliadin antibodies in autoimmune thyroid diseases.
    Akçay MN, Akçay G.
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():cclxxix-cclxxx. PubMed ID: 15244201
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the 2nd generation radio-receptional assay for anti-TSH receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1st generation and anti-thyroperoxidase antibodies (AbTPO).
    Giovanella L, Ceriani L, Garancini S.
    Q J Nucl Med; 2001 Mar; 45(1):115-9. PubMed ID: 11456370
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Serum interferon gamma levels in autoimmune thyroid disease.
    Matsubayashi S, Kasuga Y, Sakatsume Y, Akasu F, Volpé R.
    Clin Invest Med; 1990 Oct; 13(5):271-4. PubMed ID: 2125901
    [Abstract] [Full Text] [Related]

  • 11. Anti-nuclear antibody, anti-DNA, and aCL in Graves' disease patients treated with propyluracil or methimazole.
    Huang CN, Hsu TC, Chou HH, Tsay GJ.
    Lupus; 2004 Oct; 13(6):450-4. PubMed ID: 15303572
    [Abstract] [Full Text] [Related]

  • 12. Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases.
    Tektonidou MG, Anapliotou M, Vlachoyiannopoulos P, Moutsopoulos HM.
    Ann Rheum Dis; 2004 Sep; 63(9):1159-61. PubMed ID: 15308528
    [Abstract] [Full Text] [Related]

  • 13. Endothelin-1 levels in patients with disorders of the thyroid gland.
    Tilly N, Schneider JG, Leidig-Bruckner G, Sommer U, Kasperk C.
    Exp Clin Endocrinol Diabetes; 2003 Apr; 111(2):80-4. PubMed ID: 12746758
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serum IL-18 levels are not increased in patients with untreated Graves' ophthalmopathy.
    Wakelkamp IM, Prummel MF, Wiersinga WM.
    Horm Metab Res; 2004 Jan; 36(1):44-7. PubMed ID: 14983406
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
    Antonelli A, Fallahi P, Rotondi M, Ferrari SM, Serio M, Miccoli P.
    Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Should Graves' disease be considered a collagen disorder of the thyroid, skeletal muscle and connective tissue?
    Kiljanski J, Nebes V, Stachura I, Kennerdell JS, Wall JR.
    Horm Metab Res; 1995 Dec; 27(12):528-32. PubMed ID: 8750780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.